Statement 10/25/2023. January- September 2023 results.
Statement 06/27/2023. News about bilastine.
Statement 05/04/2023. Acquisition Novosci.
Statement 04/26/2023. January-March 2023 results.
Statement 03/29/2023. Capital Markets Day presentation.
Statement 03/27/2023. Approval of the scrip dividend.
Statement 02/28/2023. Business update information 2022.
Statement 12/22/2022. Appointments of Commissions.
Statement 10/27/2022. January- September 2022 results.
Statement 07/28/2022. January-June 2022 results.
Statement 04/29/2022. January-March 2022 results.
Statement 03/22/2022. Capital Market presentation.
Statement 02/25/2022. January-December results.
Statement 10/29/2021. Financial results and business update third quarter 2021.
Statement 04/12/2021. Capital market presentation.
Statement 02/26/2021. Business update information 2020.
Statement 01/15/2021. Faes Farma expands its industrial capacity.
Statement 10/29/2020. January-September results.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you deactivate this cookie we will not be able to save your preferences.This means that every time you visit this website you will have to activate or deactivate cookies again.
3rd Party Cookies
This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.
Keeping this cookie enabled helps us to improve our website.
Please, first activate the strictly necessary cookies so that we can save your preferences!